Alumis trades 4,862 contracts. The company has the following event: Conference Call and Webcast to Discuss Phase 3 ONWARD Topline Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis on Jan 6, 2026.
News: Morning Market Brief: Breakthrough Biology Meets Scalable Platforms as Innovators Surge into Focus
